of phenomena have been labeled exceptional, from policy making, 3 through the tolerance of ambiguity among gay men with AIDS, 4 to the level of commitment among nurses working with patients during Ebola outbreaks. 5 The term exceptional refers to phenomena that form an exception, are different from average, or deviate from a norm. 6 In medicine, exceptional phenomena are often equated with, but not limited to, extremely rare and unusual conditions that pose extraordinary diagnostic and/or treatment challenges. 7, 8 Peters 9 argues that clinical observations of exceptional phenomena may serve as important starting points for research that can lead to new interventions.
The cancer-specific literature on exceptional phenomena tends to focus on exploring, describing, and/or explaining what makes some patients with cancer live longer than others. This literature can be classified broadly as deriving from biomedicine or psychology. Case studies and questionnaires are the most commonly used research methods whereas inductive, qualitative approaches are used to a lesser degree. Within biomedical literature, exceptional cancer survival is often discussed in terms of "spontaneous regression" (also called "spontaneous remission"), which Papac called "one of the most fascinating phenomena observed in medicine" 10(p395) and defined as "the complete or partial disappearance of malignant tumour in the absence of therapy that is capable of inducing anti-neoplastic effects." 10(p395) Spontaneous regression has been studied and documented in literature reviews, 11, 12 case studies, 13 and theoretical discussions. 10 Spontaneous regression has been reported in relation to nearly all cancer forms, but is said to be more likely to occur in some diagnoses, with renal cell carcinoma, neuroblastoma, and malignant melanoma named as examples. 13 The extent to which spontaneous regressions occur is a subject of debate. For example, Elston refers to spontaneous tumor regressions "in approximately one in every 140 000 cases of cancer," 14(p85) whereas Kondo et al 13 and Abdelrazeq 11 believe them to be more common. Various possible explanations for spontaneous tumor regression have been discussed, with the use of certain types of CAM noted as one possibility. 12 Popular literature about exceptional recoveries, for example, books such as Bernie Siegel's 1 popular Love, Medicine and Miracles and Carl Simonton's 15 Getting Well Again propose a potential link between psychosocial variables and prolonged survival, a relationship that has also been investigated in the scientific literature. 16, 17 Conclusions from research investigating the role of psychosocial variables in survival are inconsistent. In the mid-1980s, Cassileth et al stated that "the inherent biology of the disease alone determines the prognosis, overriding the potentially mitigating influence of psychosocial factors," 16(p1555) whereas Berland argued 10 years later that there is "growing consensus" that "biological (that is, immunological) functions cannot be separated from psychological factors." 18(p17) Although debate is still ongoing about the relationship between biological and psychological mechanisms in the cancer context, 19 the role of psychological mechanisms continues to be minimized in biomedical studies on spontaneous regression or exceptional cancer survival. For example, in reviewing mechanisms underlying cancer regression both Papac 10 and Abdelrazeq 11 Like studies on spontaneous regression, most studies of exceptional recovery, regardless of approaches, use predefined, albeit varying, criteria to define what is meant by exceptional. For example, Gotay et al 20 defined exceptional survivors as those who had survived at least 5 years after diagnosis despite ≤25% probability at the time of diagnosis. In her qualitative interview study on exceptional cancer survivorship, Young defined cancer survival as "having survived beyond a medical prognosis of less than 20 percent chance of being cancer symptom free at the time of the interview." 22(p5) In addition, regardless of the specific research design, CAM use is rarely systematically monitored in studies on exceptional recoveries (with some notable exceptions 23, 24 ). This is noteworthy because several studies have found that patients with reported exceptional recoveries have used CAM. For example, Kondo et al 13 mention the use of several unspecified CAM by a patient in a case study of spontaneous regression from hepatocellular carcinoma. Cunningham and Watson 17 also found that patients with reported exceptional recoveries had practiced meditation, which they classified as a "self-help technique," although National Center for Complementary and Alternative Medicine classifies this as CAM.
In summary, there is no consensus on what exceptional recovery or spontaneous regression from cancer is and what the reasons for these phenomena might be. The multiple definitions of exceptional recoveries employed within a variety of publication forms, disciplines, and study designs add further heterogeneity to the literature. The role of CAM is prominent and mentioned across research designs and genres, although without consistency. Given the varying definitions of exceptional recoveries from cancer, the lack of systematic inclusion of CAM use, and the frequent reference to exceptional recoveries in popular literature, it is important to learn more about how patients, their significant others, and their health care providers reason about what they see as exceptional and how they view the role of CAM with regard to this.
Study-Specific Background and Methods

Project Design and Participant Recruitment
The data presented here are drawn from a larger project exploring different stakeholder perspectives of exceptional experiences in relation to CAM use and cancer, inspired by a program by the National Cancer Institute, National Ins titutes of Health and carried out in collaboration with National Research Center in Complementary and Alternative Medicine, Uni versity of Tromsø, Norway. Prior to initiating this project, ethical approval was received from the appropriate research ethics committee in Sweden.
We used a critical incident technique (CIT) 25 to recruit accounts of positive or negative exceptional sickness trajectories in relation to CAM use through a mass media invitation, although we only received reports framed as exceptionally positive. CIT was first described by Flanagan, 25 who argued for the study of extreme incidents as a way of also understanding what occurs more commonly. Norman et al 26 27 ) .
For the analysis presented here, we selected 5 cases for which data were available from multiple stakeholder perspectives (see Table 1 ). In 4 of these 5 cases, patients contacted the researchers themselves, whereas in 1 case (Catherine, see Table 1 ), the CAM provider reported the case with the patient's consent. Open interviews with participants who had actively contacted the researchers began with an invitation to talk about why they had made contact and to share their story. This was to enable and also encourage participants to describe in their own words what they felt was exceptional in the reported case. Follow-up questions were used for clarification. Subsequently, after receiving patient consent, other stakeholders were contacted and interviewed. These interviews generally began with an open question referring to the specific patient, for example, "Can you describe your experiences and view as significant other/BHC provider/ CAT provider about what has happened to X (name of patient)?" Interviews generally lasted between 1 and 3 hours. All but 1 interview were audio-recorded and later transcribed verbatim. One CAM provider preferred the interview to be documented by notes.
Data Analysis
We wanted to examine what constitutes the exceptional in sickness trajectories, how this is explained, and what sim ilarities and differences both within and between individual patient cases and different stakeholder perspectives were described. After repeated reading of the 16 interviews, all transcript sections of relevance were extracted to form a new data set for more focused analysis. This condensation enabled us to preserve and highlight the contextual aspects of the descriptions on exceptional trajectories while remaining cautious not to omit relevant interview data. 28 At this point one researcher focused on analysis of data by case while another analyzed data by stakeholder perspective. In the analysis of cases, all stakeholder perspectives for one case were analyzed together. In contrast, the analysis of perspectives concentrated on all data from one stakeholder perspective at a time. The selected sections of the interview text were divided into meaning units consisting of one or more sentences about a cohesive topic. 28 Each meaning unit was then rephrased to elucidate its content in more abstract terms. Meaning units with similar content were grouped together and labeled with codes. Analysis was conducted by moving back and forth between each interview in its entirety and relevant coded sections. Two interrelated overarching themes were constructed from this analysis: Theme A (Conceptualizations of the exceptional in sickness trajectories) and Theme B (Attributions for exceptional trajectories). For the purpose of analytic clarity, these themes are presented separately. In the themes, speakers' emphasis is shown by capital letters. The National Center for Complementary and Alternative Medicines classificatory system, rather than specific modalities, has been used to describe CAM in an effort to maintain participants' anonymity.
Results
Whereas the purpose of the mass media invitation was to locate positive or negative exceptional accounts, few stakeholders explicitly used this term. We however use this term as an analytic construct to describe the manner in which the interviewees spoke of their positive sickness trajectories. Andrea's case, presented in Box 1, is used as an exemplar to illuminate and contrast similarities and differences within and between stakeholder perspectives in relation to the themes.
We found that all stakeholders-patients, their significant others, BHC providers, and CAM providers-framed their reports of sickness trajectories along a continuum between the exceptionally positive and the ordinary with varying emphasis on well-being and/or long-term survival (Theme A). Regardless of whether patients' trajectories were described as exceptional or not, all stakeholders discussed possible explanations for these positive trajectories (Theme B).
Theme A: Conceptualizations of the Exceptional in Sickness Trajectories
Well-being. A core finding in patients' descriptions was their emphasis on exceptional well-being not only with regard to unexpectedly long survival but also as an independent outcome. Andrea talked about her well-being in conjunction with remission (see Box 1), whereas others talked about well-being despite advancing disease and an unknown future. Dinah, for example, said the following: "I don't know how long I'm going to live but I'm living well in any case. I feel good, I can do what I want." Significant others spoke similarly about their spouses' well-being despite advanced cancer. Most clearly, Victor's spouse emphasized his well-being as exceptional in light of his tumor burden: "This large tumor, like, oh my goodness, how can he go around with that and still feel as GOOD as he does?" Well-being as described by patients and significant others appears to be a central part of defining sickness trajectories as exceptional irrespective of disease severity and stage.
Catherine's description is unusual in that she did not view her well-being in relation to advanced cancer as exceptional but instead emphasized how her long experience of chronic illness prior to her cancer diagnosis had taught her the necessity of actively striving for well-being. In this way, Catherine's well-being is framed as a continuation of her lifelong efforts to distinguish herself from her diseases:
Then [when diagnosed with a chronic disease as a teenager] I learned somehow not to IDENTIFY myself as an SICK person, instead I was Catherine, just like anyone else . . . I mean if I become the one over there with X [chronic disease] or that cancer, then I just disappear as a person. . . . I just become a CASE.
Patients also described well-being in terms of finding meaning in life between diagnosis with a potentially lethal disease and the time of death itself. Catherine said her CAM use helped her both find meaning in this situation and to live a good life: "After having surgery to remove the eleventh tumor I'm feeling pretty good . . . you don't die immediately. You can live a good life anyway."
Patients (and their significant others) also described exceptional well-being in terms of strengthening their body and preventing deterioration as a result of BHC treatment. Peter spoke of well-being in terms of living a good and active life:
You can say that things have turned out well in my case. Well, I have no problems with my urinary tract and no problems with my intestines and I'm still potent and I don't even think I'm sterile. Ehh, I'm still fertile, you know.
In addition, patients also expressed experiencing exceptionally fewer or milder side effects from BHC treatments when compared with other patients, as illustrated by Peter: "You meet some other fellows [laughter] [in the waiting room at the BHC clinic] . . . there were those who had it much worse than me when it comes to side effects, so I believe that this is a little exceptional." Peter, who is also a professional provider of the specific CAM that he used, said that BHC providers had not commented on what he saw as exceptional well-being verbally or in his medical records. Like Peter, other patients and CAM providers questioned why BHC providers did not express interest in the effects of their CAM use.
Box 1. Andrea's Case Description: Based on Interviews With Andrea, Her Husband, BHC Provider, and CAM Provider
Andrea is a middle-aged Swedish woman, living with her family. Interviews have been conducted with Andrea, her husband, her complementary and alternative medicine (CAM) provider, and her biomedical health care (BHC) provider. Andrea's CAM provider works at a private clinic and her BHC provider works at an oncology department at a university hospital.
Andrea began by describing how she received a gynecological cancer diagnosis about 7 years earlier. She was treated surgically, saying that shortly thereafter she was "declared healthy" with follow-up checkups occurring regularly. Four years later she felt "something growing" in her stomach. She described how she sought care for about a year without BHC providers finding the cause of her symptoms. Andrea said that 2 new tumors were then detected in her abdomen. She was transferred to specialist oncologists, and imitated their voices when she said "We're going to try chemotherapy but we don't know which kind we will start with". Later in the interview, Andrea said the BHC providers told her "they didn't have much hope," and evaluated the situation herself, saying that her "odds were bad." She described the encounter with the BHC provider saying he took time to "explain to me that I have to accept my diagnosis." She said that BHC providers take their time when it comes to explaining to people "that they are actually going to die" but that this is not otherwise the case. Andrea said it was not problematic for her to accept the severity of her cancer as "you become so incredibly aware of your mortality." Her problem was rather to "have the strength to get well and survive."
Andrea said that it is important to get correct information, but it can be done "in different ways." Andrea said she wanted to know if she could do something herself and learned that there was nothing she could do, "it's sufficient to be treated with medicine and either you survive or not."
Andrea underwent a second surgery and was subsequently treated with chemotherapy. She described this treatment period as "very tough," experiencing many side-effects from chemotherapy. She said her treatment was interrupted in late summer because it "didn't have any effect." Andrea also said that she was discontent with the care she received because she "didn't have one but rather seven physicians" during this period. She explained how she "demanded to have one doctor [only]" after the summer. Her request for one consistent BHC doctor was met and Andrea spoke of the confidence she felt in the "new" physician. She explained how she also started a new chemotherapy regimen and at the same time contacted a CAM provider. Andrea said she had heard that this CAM provider had "good results with cancer patients." At this point in the interview, Andrea said that she then "had decided for herself that she would get well" and that she had started her own "program" including use of several CAMs, primarily an energy-based therapy. She said she felt her CAM provider "pepped her up" and came to experience this therapy as a "life line." Andrea's husband described her as always "much more positive" and "full of vitality" after seeing her CAM provider. He described his ideas about the best way for him to support Andrea: "I'm of most use if I readily believe she'll get well" rather than "counting the odds" about her disease prognosis.
Andrea described experiencing an improvement during the next fall saying that her "test results improved," "she felt much better," and was relieved by "life becoming normal again." She described tumor effects saying "It [a malignant lymph node] had calcified and fallen off, the right side had fallen off and on the left it had diminished." Andrea said she was now [at the time of the interview] "almost well" and contrasted her improvements to her previous sense of despair after the first recurrence: "It is one thing to make it from the start, but a recurrence feels almost insurmountable, yes, but now it is almost ok."
Andrea also described her BHC doctor as being very pleased with her improvement. During the interview, her BHC doctor responded to a question about the changes in her tumor by saying the following: "Here we have a change in the tumor . . . It is a partial remission, it is what we say, it isn't complete but it [the tumor] has diminished without doubt." When speaking about tumor changes in general, Andrea's BHC doctor also said that while tumor remission is a good sign one has to "be a bit cautious in interpretations" and "most likely, the disease is still there." In a later follow-up letter to the interviewer, this BHC doctor wrote about Andrea's remission as not exceptional: "I don't remember if it was clear in our discussion that I don't think that Andrea's disease trajectory is exceptional." In this letter he also proposed an explanation for her improvement: She [Andrea] had tried different kinds of chemotherapy without effect and in that situation we decided to start a new kind of chemotherapy with a somewhat different mechanism of action. . . . Andrea's cancer responded well to that treatment. I don't think one can disregard this fact. Although it could have been due to other factors, it corresponds well in time.
Andrea's recovery was also described by her CAM provider who related Andrea's improvements to similar recoveries of other cancer patients receiving the same CAM treatment. When the interviewer asked if Andrea's improvement was typical, the CAM provider responded affirmatively. Andrea's CAM provider said that people seeking help at this clinic generally have advanced cancer and that it was possible to give examples of more than 50 cases similar to Andrea's who had recovered after being treated with the same therapy. The CAM provider spoke of BHC providers' lack of interest in Andrea's case: "How can they see so many things and not wonder?" This CAM provider also emphasized that Swedish law prohibits people working outside the BHC to say that they cure cancer and that "You only HELP to cure someone."
When Andrea was asked by the interviewer what she believed had contributed most to her recovery, she answered:
It's really difficult to answer but you could say I have put a lot of trust into X [CAM therapy] . . . it has felt like a very important source of security . . . when I started. Yes, that's perhaps the most important thing but it is hard to say because it is also a combination of different things.
She also said the following: Later in the interview Andrea again used reported speech, imitating her BHC provider, saying that "[he] cannot explain why but that it sometimes heals." She also talks about her own role during the treatment: "I was strengthened in that it mattered what I, myself, did during that treatment, that it mattered." Andrea's husband also emphasized the importance of Andrea's desire to live: "I believe that will is also important for healing."
The interview with Andrea was conducted 3 years after her first recurrence, and she lived for another 4 years before dying from cancer.
Based on the interviews with both BHC providers and patients, BHC providers did not speak of well-being as part of an exceptional sickness trajectory. However, CAM providers' descriptions of patients' well-being as exceptional was often in line with patients' descriptions. Although Andrea's CAM provider did not describe Andrea's trajectory in much detail apart from referring to it as "typical," Dinah's CAM provider described her trajectory in terms of both exceptional well-being and tumor regression: "Some metastases have gone into regression and some have disappeared. And quality of life is getting better and better so soon Dinah will be playing golf again." In other descriptions by CAM providers, there was a pronounced emphasis on exceptional well-being, including the patient's ability to live a good life despite the effects of BHC treatment and metastasized cancer. Catherine's CAM provider talked about her case as "remarkable" using reported speech:
In the middle of everything, with an illness that has given her a total of 10 metastases in 3 years, she [Catherine] says: "I am pretty satisfied" . . . [that] makes this story a bit different compared to the standard story, and a bit remarkable.
This is the only case in this study in which the CAM provider, but not the patient, repeatedly described the degree of well-being experienced as exceptional.
Long-term survival. Another core finding in patients' descriptions was their emphasis on exceptional long-term survival. Patients' survival after being diagnosed with recurrence or metastasis, although this was not referred to in time, ranged between 4 and >7 years (see Table 1 ). Like Andrea (see Box 1), other patients emphasized that the length of their survival had surpassed their own or their BHC/CAM provider's expectations. Andrea contrasted her past experience of recurrence as something she felt was "almost insurmountable" with her positive state of wellbeing at the time of the interview. Using reported speech to dramatically refer to his unexpectedly long survival, Victor quoted his CAM provider: "Once when we got there [to the CAM provider] he looked at me and said: 'What the hell are you doing here? You should be dead' [laughter] ." In a similar vein, referring to her own previous fear of imminent death, Dinah said the following: "[I] felt much more alert, because in November I actually thought that I would not survive Christmas. That's how sick I was.
[I] had my birthday the other day and thought 'Wow, one more year!'" Significant others were less explicit, generally describing spouses' survival time in contrast to their own initial negative expectations. Peter's wife talked about "becoming a widow within half a year, a year," and Victor's spouse spoke of his diagnosis as "death sentence."
Similar to well-being, patients compared their own survival to stories about the recovery of other patients who used the same CAM. Andrea said that she had heard that her CAM provider had "good results with cancer patients" (see Box 1) . Victor gave several concrete examples of other patients who had survived after using the same CAM treatment:
We have seen, almost everyone who comes there [the CAM clinic]. I remember one man who came in a wheelchair . . . His skin looked a bit like wet rice paper, yellowish and completely wasted . . . After four or five days his skin started to look like SKIN. And after one and a half weeks the old man was pretty active and up and about again, you could say. CAM providers, on the one hand, described reported trajectories with long-time survival as common in their own practice, whereas, on the other, they simultaneously described these positive trajectories as otherwise exceptional. For example, Andrea's CAM provider agreed that Andrea had recovered against all odds but also described her as "typical," rather than unique, for that treatment (see Box 1). Victor's CAM provider described Victor in a similar manner as one among many "good cancer stories" in his "long row of cases" at the clinic. However, in contrast to Victor's own description, his CAM provider did not describe the trajectory as exceptional, instead providing examples of other patients whose survival was "absolutely very unusual" and "even more fantastic." Dinah's CAM provider was an exception in describing Dinah's trajectory as a rare phenomenon: Dinah is the only case in which there is a clear congruence between a patient's and a CAM provider's description of the sickness trajectory as exceptional.
All BHC providers spoke of patients' trajectories in positive terms but differed from patients and CAM providers by describing these trajectories as within the normal limits of disease and treatment response. As in Andrea's case, Catherine's BHC provider discussed her trajectory as within normal limits of tumor growth: "It [Catherine's cancer] often has a very serious course, but in this case it's a slowly growing tumor and you can live with it for many years, and she [Catherine] has done that, it's almost 20 years now." BHC providers could also describe patients' trajectories as representing successful, but not exceptional, BHC tumor control: "During the time I [Dinah's BHC provider] have had Dinah, her disease has been kept under control pretty well, she has a spread disease and it's been kept under control." There was thus a discrepancy between patients' and BHC providers' descriptions with regard to what was considered an exceptional sickness trajectory in all 5 cases.
Theme B: Attributions for Exceptional Trajectories
Agency and responsibility. Andrea had multiple explanations for her positive sickness trajectory including emphasizing the importance of her own role (see Box 1) . Other patients, like Peter, similarly described that taking an active role and taking responsibility for their illness had positive impact on their sickness trajectories: "As I believe, the trajectory has been influenced by the fact that I've taken responsibility . . . I'm convinced of that."
Patients also spoke of the importance of understanding potential psychological causes for their cancer to determine their future behavior and strategies, saying this influenced how they viewed and experienced their cancer sickness and/or trajectory. For example, Dinah said the following:
First . . . I believe that it's very important to know WHY I got cancer right now. To see these pieces and be able to treat them and say "okay, I didn't feel good about this and now I got to do something about it," or "I WANT to do something about it." So that I feel BETTER and don't just continue in the same footsteps. I believe that's also VERY important.
Patients described their own role as an active one, recognizing that they were empowered by support from other individuals, including their significant others and BHC and CAM providers. Victor spoke about "the cancer project," further illustrating how his active role contributed to his survival: Like patients, significant others also described the important role of support from other individuals, emphasizing its positive influence on the sickness trajectory. Peter's wife spoke of the family's positive influence on his sickness trajectory metaphorically: "We have a medicine and that's our grandchildren. . . . A very powerful and good medicine. Because I said 'We have to look for resources that we have around us.' And grandchildren are important."
BHC providers talked about the importance of patients' involvement in their treatment and disease as having a psychological benefit rather than as something that could affect the sickness trajectory per se. Andrea's BHC provider said it was important that Andrea felt that she "has done what she can." Although BHC providers raised the issue that patients with certain personal characteristics may do better than others, they remained vague regarding this issue. Catherine's BHC provider, for example, spoke about Catherine as a very active and strong person saying that "patients with great life energy and a will to live, they are much better off." CAM providers were more similar to patients in the way they spoke about patients' active roles in relation to the sickness trajectories. Andrea's CAM provider was an exception in that this was not mentioned in relation to Andrea's improvement (see Box 1) . Other CAM providers spoke about the importance of patients actively engaging in their cancer illness, for example, as explained by Victor's CAM provider:
You can take chemo, everything can go fine. You can take chemo and everything can go badly. You can take natural medicine and everything can go fine. You can take natural medicine and everything can go badly. Nobody can guarantee. Only one person can make the decision and that is you [the patient].
Victor's CAM provider also talked about the importance of being active in another sense, through frequent and regular exercise:
Cancer is like a vampire, it sucks energy from the patient . . . So if you are conscious about that . . . walk, run, swim, bike, it doesn't matter, a certain distance every day at the same time . . . then you have complete control over your cancer if you continue to do that.
Patients described their active role as a conscious choice in the way they approached life and/or as part of their personality. All significant others also talked about their spouses' personality in terms of their strong will. Peter's spouse emphasized the importance of her husband's capacity to find new solutions as he struggled to maintain well-being after 2 cancer diagnoses: "He has his own way of coping that has been an asset for him in this sickness and he pulls himself up and finds new ways." Andrea's husband went further saying he believed that the will to get well played a strong role in recovery from cancer (see Box 1).
To varying degrees, significant others emphasized that their own proactive stance also had positive influence on patients' trajectories. Andrea's husband described actively deciding to take a passive role in seeking information, saying he refrained from finding out more information about her prognosis as he "had to believe" that Andrea would get well (see Box 1). Others described taking a more active role in influencing decisions. Victor's wife initiated a number of CAM treatments for her husband when he was too sick to do so. Peter's wife had a similar role in her husband's treatment choices. As Peter had already initiated CAM treatments himself, she encouraged him to use BHC treatment by advocating the more invasive of 2 BHC treatment alternatives: "He [BHC doctor] wanted Peter to surgically remove the tumors, not burn them off. But I remember Peter had doubts. I said 'I would operate them [tumors],' so I persuaded him a bit."
Treatment-related explanations. Andrea was similar to other patients in pointing out the role that particular therapies had played in her recovery. Although she pointed to one CAM therapy as especially important, Andrea also said she could not rule out the possibility that her BHC treatments had contributed to what she saw as her exceptional improvement (see Box 1). Others more directly described how their symptoms and tumors diminished or disappeared as a result of the combined use of CAM and BHC treatments.
Like patients, significant others explained patients' improvements as related to combinations of BHC and CAM. Peter's wife attributed his well-being specifically to his CAM use, saying "It has saved him, I don't think he would feel this well if he hadn't had it." On the other hand, she attributed more objective positive outcomes to the combined use of CAM and BHC: "These medicines [CAM] and the usual Western methods with radiotherapy and surgery, all these together led to the good results." In the same vein, Andrea's husband said it was impossible to say which treatment (CAM or BHC) was the reason for her positive response as she used both simultaneously.
In contrast, BHC providers related patients' positive trajectories only to those treatments prescribed by the BHC. As seen in Andrea's case (Box 1), her BHC provider described her positive trajectory as a likely result of BHC treatment. The account by Dinah's BHC provider is similar, saying that this response to therapy is not uncommon:
Well, I have more patients than [Dinah] who have had the same, what we call tumor burden . . . who have responded well to antihormonal treatment only, or this endocrine therapy. So even if it doesn't work for everyone, it works for sufficient number [of patients] for this effect to come only from this antihormonal treatment.
BHC providers discussed how they tried to avoid making predictions, but also retrospectively discussed patients' treatment response in relation to the initial intentions. Catherine's BHC provider explains that even Catherine's initial treatment was palliative rather than curative: I don't speak about the future so much anymore since I have been wrong so many times. . . . with experience as a specialist you have to vary different chemical methods and even surgery. And try to help her, but we're in the phase we call palliation, we try to ease her symptoms. And that phase can go on for a long time, it's so different for different diseases and different individuals.
As the case with BHC providers, CAM providers explained their patients' trajectories as primarily related to their own domain of practice, that is, CAM treatments they had prescribed. Andrea's CAM provider spoke implicitly about one CAM therapy as the reason for Andrea's improvement (see Box 1). Catherine's CAM provider explicitly described the relationship between one CAM and a positive trajectory: "I think about . . . how quickly she reacted to this X [a biologically-based therapy] . . . And she was totally pain-free as long as 4 to 5 months after this treatment." Although Andrea's and Catherine's CAM providers related their patients' improvements to a single CAM therapy, other CAM providers related patients' improvements to the combined use of several CAM therapies. Dinah's CAM provider, for example, said "I see X [a manipulative and body based therapy] as most important, in addition to her changes in diet and the dietary supplements."
Discussion
This analysis of 5 cases reported as exceptional shows similarities and differences in the perspectives of patients, their significant others, and CAM and BHC providers. Although the different stakeholders unanimously agreed that these cases were positive, we found no case in which all stakeholders viewed the trajectory as exceptional, nor did different stakeholders share conceptualizations of what constituted the exceptional or attributions for the positive trajectories.
Stakeholders' views of the reported sickness trajectories could be located along a continuum between the exceptional and the commonplace, with different degrees of emphasis on well-being versus unexpectedly long survival. With one exception, patients and significant others emphasized the reported trajectories as exceptional in terms of both well-being and long-term survival with reference to their own expectations and those of their providers, as well as by comparison with other patients.
In contrast, none of the interviewed BHC providers framed the reported trajectories as exceptional, referring to patients' survival as within normal limits of the disease trajectory and without reference to well-being. CAM providers' views of the exceptional were similar to the views of both patients and BHC providers. CAM providers' descriptions were somewhat paradoxical, as they described patients' well-being and long-term survival as exceptional in general, although not exceptional for their own practices.
When explaining reasons for their positive sickness trajectories, patients and significant others emphasized their own active roles and responsibilities, as well as their combinations of BHC and CAM treatments. BHC providers and CAM providers related positive outcomes to treatments prescribed within their own domain of knowledge and practice.
To our knowledge, this study is unique in openly exploring and analyzing what constitutes the exceptional in sickness trajectories from multiple stakeholder perspectives. In line with the reviewed background literature, the exceptional in this study is found to be a relative phenomenon by showing that stakeholders' conceptualizations of, and attributions for, exceptional sickness trajectories may be relative to the different domains of health care practice.
Although well-being represented a central aspect of exceptional trajectories for patients, significant others, and CAM providers in this study, well-being is rarely discussed in the literature on exceptional trajectories. Other research, however, suggests that expected and experienced well-being as a result of CAM use is an important reason for cancer patients initiating and continuing CAM use. 29 In addition to reflecting individual motivations for and positive experiences of CAM use, the differences in focus on exceptional well-being versus survival in this study might in part reflect Swedish legislation. A Swedish health care act prohibits nonlicensed providers to treat cancer and limits cancer treatment by licensed BHC providers to the principles of "science and tested experience." Although these principles prohibit licensed BHC providers from using CAM for the treatment of cancer tumors, an emerging evidence base supporting the use of some CAM to increase cancer patients' well-being opens up an hypothetical possibility for licensed BHC providers to recommend some forms of CAM to increase well-being. 30 This legislation may in part explain why the interviewed CAM providers, 3 of whom were also licensed BHC physicians, tended to emphasize their patients' exceptional well-being.
Moreover, most CAM therapies are not part of the publicly financed health care system in Sweden, and CAM providers may thus have a greater need for legitimization compared with BHC providers. [31] [32] [33] Tovey 34 distinguished between formal and professional legitimization processes in his discussion of UK alternative practitioners and intersectoral acceptance. He describe professional legitimacy as "the acceptance or denial of the occupational validity of practitioners or groups by another" 34(p1129) and formal legitimacy as "a matter of political inclusion and exclusion." 34(p1129) In our study, professional legitimacy may have been a factor in the interviews with CAM providers, as the study was based at a medical university. Patients reporting exceptionally positive experiences of CAM use in combination with BHC may have a need for formal legitimization considering their extensive use of CAM as self-care therapies. The hypothesized quest for different forms of legitimization of CAM use may thus have attracted both patients and CAM providers to report cases to this study. However, it is possible that the limits of the Swedish health care act may have influenced others in the opposite direction, that is, not to report cases to this study due to the legal restrictions.
While CAM reports may in part be explained by a need for legitimization, BHC providers' descriptions of sickness trajectories as unexceptional might be understood in relation to the close relationship between exceptional and miraculous sickness trajectories. 10, 11, 35 According to Kappauf, 35 the risk of equating the concept of exceptional with "miracle cures" has led to reluctance among BHC professionals to focus their attention on exceptional sickness trajectories. Although it is possible that miracle cures serve as a tool for the promotion of certain CAM, our results indicate that both CAM and BHC providers in this study shared a tendency to attribute positive sickness trajectories to their own realm of knowledge and practice.
In their discussion of the persuasive appeal of alternative medicine, Kaptchuk and Eisenberg argue that although there is considerable overlap between BHC and CAM, BHC has a "more rigorous and self-critical scientific method" 36(p1064) and that "when it [BHC] is honest," [it is] "less optimistic, and more realistically [than CAM] accepts the limitations and finitude of the human condition." 36(p1064) Our findings suggest that differences in outlook between BHC and CAM may not relate to differences in realism but rather to different frames of reference. Neither patients nor CAM providers in this study described being realistic about the severity of their diagnosis as in opposition to being optimistic. In contrast to both BHC and CAM providers, patients did not attribute their exceptional wellbeing and long-term survival to a single treatment but rather to multiple factors with an emphasis on their own active role. The emphasis on factors contributing to recovery or well-being as within one's own sphere of influence may, as Tishelman 37 suggests, be seen as a way to enable "individual success." Patients' descriptions also resemble what Ezzy 38 characterizes as polyphonic illness narratives, where a person finds resolution in focusing on the present while embracing an unknown future. These kind of narratives stand in stark contrast to the linear illness narratives often portrayed in the literature on exceptional sickness trajectories where a successful story is defined by a desirable endpoint or predictable future. 11 The analysis presented here indicates that the goals of integrative cancer care and the structure of polyphonic narratives are in line with the manner patients in this study described their exceptional sickness trajectories.
Although the results from this study cannot directly be generalized to a larger population, the case study design used here has enabled us to identify a range of views of what constitutes the exceptional, both within single cases and within stakeholder perspectives. Our results thus complement previous research that dichotomizes patients' own perceptions of their survival as either "remarkable" or "unremarkable." 20, 39 Gotay et al, 20 for example, hypothesized that if an individual perceives his or her own survival probability as either 0% or 100%, every survivor may then consider himself or herself as "exceptional". In contrast, Killoran et al 39 found that individuals surviving more than 20 years after a diagnosis of metastasized cancer described their recovery as unremarkable, and suggest that individuals' stories may modify over time to reflect North American cultural values that "normalize adversity."
Individuals' accounts of recoveries from cancer, like accounts on health and illness in general, thus exist both in private and public spheres. 40 In this study, the accounts of exceptional sickness trajectories may in part be understood in relation to the lack of a public sphere for discussing experiences related to CAM use in the context of cancer. This may create a struggle for legitimacy that can explain why patients portray their experiences as exceptional, why CAM providers paradoxically described patients' sickness trajectories as both exceptional and commonplace, and why both CAM providers and patients described a lack of interest in these trajectories from BHC providers. The exceptional in cancer trajectories is an arena where professional and formal legitimization of practice comes forth in different ways for CAM and BHC providers and where patients who choose to use CAM in conjunction with BHC treatments seem to enter a terra non grata.
